Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
Agilent's sgRNAs are a reference for quality nucleic acids. Using a patented chemistry for the synthesis RNA oligonucleotides up to 160 nt, Agilent sgRNA enables quick and easy editing with the highest indel frequency and reproducibility. Get high-quality sgRNAs with parented chemical modifications to improve their efficiency, stability, and specificity in various cell types.
Language:
English
Who can attend? Everyone
Featured Presenters
MS, MBA, Market Development Manager, CRISPR Genome Engineering, Agilent
Dan brings over a decade of experience in the field of genome editing and its application. He has operated in key roles in R&D, technical sales & marketing at leading companies in the field, including Agilent and Sigma-Aldrich. Dan received his bachelor's degree in Biology from Bradley University, a master's degree in Biochemistry from Southern Illinois University-Edwardsville, followed by a M.B.A. from Webster University.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.